Inhibitory effects of compounds isolated from roots of Cynanchum wilfordii on oxidation and glycation of human low-density lipoprotein (LDL)

被引:11
|
作者
Kim, Jae-Yong [1 ]
Lee, Jung Woo [1 ]
Lee, Jin Soo [2 ]
Jang, Dae Sik [2 ]
Shim, Sang Hee [1 ]
机构
[1] Duksung Womens Univ, Coll Pharm, 144 Gil 33 Samyang Ro, Seoul 01369, South Korea
[2] Kyung Hee Univ, Grad Sch, Dept Life & Nanopharmaceut Sci, 26 Kyungheedae Ro, Seoul 02447, South Korea
基金
芬兰科学院; 新加坡国家研究基金会;
关键词
Cynanchum wilfordii; Phenolic compound; Pregnane-type steroids; Low-density lipoprotein (LDL); Oxidation; Glycation; C-21 STEROIDAL GLYCOSIDES; CHEMICAL-CONSTITUENTS; APOLIPOPROTEIN-B; ATHEROSCLEROSIS; IDENTIFICATION;
D O I
10.1016/j.jff.2019.05.045
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Low-density lipoprotein (LDL) modification such as oxidation and glycation has been known to play a significant role in the initiation and progression of atherosclerosis. The inhibitors on LDL modification have been emerged as a new strategy to be a supplement for prevention of atherosclerosis. In an effort to discover inhibitors on LDL modification from natural products, phytochemical investigation on Cynanchum wilfordii roots were performed, leading to isolation of acetophenones (1-6) including a new one (1) and nine pregnane-type steroids (7-15). The structure of the compound 1 was determined by analysis of 1D and 2D NMR spectral data analysis. All the isolated compounds were evaluated for their inhibitory activities against LDL modification. Among them, compounds 2 and 5 strongly inhibited LDL oxidation and glycation. These results suggest that compounds 2 and 5 from C. wilfordii may provide potential protective effects against atherosclerosis via inhibition of LDL oxidation and glycation.
引用
收藏
页码:281 / 290
页数:10
相关论文
共 50 条
  • [1] Inhibitory Activities of Compounds from the Twigs of Garcinia hombroniana Pierre on Human Low-density Lipoprotein (LDL) Oxidation and Platelet Aggregation
    Saputri, Fadlina Chany
    Jantan, Ibrahim
    PHYTOTHERAPY RESEARCH, 2012, 26 (12) : 1845 - 1850
  • [2] Effects of glucose and α-tocopherol on low-density lipoprotein oxidation and glycation
    Chang, CJ
    Hsieh, RH
    Wang, HF
    Chin, MY
    Huang, SY
    ROLE OF THE MITOCHONDRIA IN HUMAN AGING AND DISEASE: FROM GENES TO CELL SIGNALING, 2005, 1042 : 294 - 302
  • [3] DIFFERENTIAL INHIBITION OF HUMAN LOW-DENSITY LIPOPROTEIN (LDL) OXIDATION BY THYRONINES
    HANNA, AN
    NEWMAN, HAI
    ARTERIOSCLEROSIS, 1989, 9 (05): : A737 - A737
  • [4] Low-density lipoprotein oxidation biomarkers in human health and disease and effects of bioactive compounds
    Winklhofer-Roob, Brigitte M.
    Faustmann, Gernot
    Roob, Johannes M.
    FREE RADICAL BIOLOGY AND MEDICINE, 2017, 111 : 38 - 86
  • [5] CHARGE HETEROGENEITY OF HUMAN LOW-DENSITY LIPOPROTEIN (LDL)
    GHOSH, S
    BASU, MK
    SCHWEPPE, JS
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1973, 142 (04): : 1322 - 1325
  • [6] Decrease in the particle size of low-density lipoprotein (LDL) by oxidation
    Hidaka, A
    Inoue, K
    Kutsukake, S
    Adachi, M
    Kakuta, Y
    Kojo, S
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (11) : 2781 - 2785
  • [7] Effects of oxidation on the structure and stability of human low-density lipoprotein
    Jayaraman, Shobini
    Gantz, Donald L.
    Gursky, Olga
    BIOCHEMISTRY, 2007, 46 (19) : 5790 - 5797
  • [8] Novel low-density lipoprotein (LDL) oxidation model: Antioxidant capacity for the inhibition of LDL oxidation
    Chu, YF
    Liu, RH
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2004, 52 (22) : 6818 - 6823
  • [9] INJURIOUS EFFECTS OF LOW-DENSITY LIPOPROTEIN (LDL) ON HUMAN MESANGIAL CELLS (HMC)
    KEANE, WF
    PHILLIPS, J
    KASISKE, BL
    ODONNELL, MP
    KIM, Y
    KIDNEY INTERNATIONAL, 1990, 37 (01) : 509 - 509
  • [10] Chromium and human low-density lipoprotein oxidation
    Lapenna, Domenico
    Ciofani, Giuliano
    JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 2020, 59